[1] |
DUNMIRE S K,HOGQUIST K A,BALFOUR H H.Infectious mononucleosis[J]. Curr Top Microbiol Immunol,2015,390(Pt 1):211-240.
|
[2] |
SIXBEY J W,NEDRUD J G,RAAB-TRAUB N,et al.Epstein-Barr virus replication in oropharyngeal epithelial cells[J]. N Engl J Med,1984,310(19):1225-1230.
|
[3] |
HADINOTO V,SHAPIRO M,SUN C C,et al.The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output[J]. PLoS Pathog,2009,5(7):e1000496.
|
[4] |
HOCHBERG D,SOUZA T,CATALINA M,et al.Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting,latently infected cells[J]. J Virol,2004,78(10):5194-5204.
|
[5] |
TAYLOR G S,LONG H M,BROOKS J M,et al.The immunology of Epstein-Barr virus-induced disease[J]. Annu Rev Immunol,2015,33:787-821.
|
[6] |
CAO P,ZHANG M,WANG W,et al.Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients[J]. BMC Infect Dis,2017,17(1):323.
|
[7] |
马闪珊,邵丽佳,孙冬梅. EB病毒抗体检测对诊断儿童传染性单核细胞增多症的临床价值[J]. 中国卫生检验杂志,2017,27(8):1131-1132.
|
[8] |
王晓亮,刘晓莺. EB病毒抗体与DNA载量联合检测在儿童传染性单核细胞增多症中的诊断价值[J]. 国际病毒学杂志,2016,23(4):267-270.
|
[9] |
邓坤仪,彭建明,范汉恭,等. 三种实验室检测方法在儿童传染性单核细胞增多症的诊断应用[J]. 分子诊断与治疗杂志,2016,8(1):37-41.
|
[10] |
赖书台. 实验室检测在早期诊断传染性单核细胞增多症的意义[J]. 中国现代药物应用,2015,9(12):49-51.
|
[11] |
麻志慧. EB病毒抗体检测在传染性单核细胞增多症中的临床意义[J]. 赤峰学院学报(自然科学版),2014,30(7):102-103.
|
[12] |
伍红,龙峰,段纯,等. 四联EBV特异抗体检测在传染性单核细胞增多症诊断中的运用[J]. 医药前沿,2012,2(4):105-107.
|
[13] |
严海燕,罗晓红,陈娟,等. EB病毒抗体和DNA联合检测可提高儿童传染性单核细胞增多症的诊断灵敏度[J]. 中国微生态学杂志,2011,23(6):540-542.
|
[14] |
袁利群,叶剑荣. EB病毒抗体检测在儿童传染性单核细胞增多症诊断中的应用[J]. 湖南师范大学学报(医学版),2010,7(3):16-19.
|
[15] |
陈琴琴. 血清EBV-IgM抗体对儿童传染性单核细胞增多症临床诊断的意义[J]. 实验与检验医学,2009,27(5):564.
|
[16] |
曹碧红. 传染性单核细胞增多症EBV-IgM抗体检测的临床意义[J]. 海南医学,2008,19(4):46-47.
|
[17] |
汪小瑛. 传染性单核细胞增多症患者血清EBV-IgM抗体检测分析[J]. 海峡预防医学杂志,2005,11(5):82.
|
[18] |
邢晋苓. 抗EB抗体检测对诊断儿童传染性单核细胞增多症的意义[J]. 海南医学,2005,16(6):145.
|
[19] |
向龙,毛萌,付雪梅. EBV-IgM抗体检测在儿童传染性单核细胞增多症临床诊断中的应用[J]. 华西医学,2003,18(3):372.
|
[20] |
邹亚伟,吴梓梁,赵惠聪. 传染性单核细胞增多症实验诊断初探[J]. 临床儿科杂志,1998,16(4):226-227.
|
[21] |
吕善根,谷志远,张霭云,等. 抗EB病毒壳抗原抗体(VCA-IgM、IgG)测定对传染性单核细胞增多症诊断意义的探讨[J]. 中国人民解放军军医进修学院学报,1989,10(1):56-58.
|
[22] |
ALMOHMEED Y H,AVENELL A,AUCOTT L,et al.Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosis[J]. PLoS One,2013,8(4): e61110.
|
[23] |
TZELLOS S,FARRELL P J.Epstein-barr virus sequence variation-biology and disease[J]. Pathogens,2012,1(2): 156-174.
|
[24] |
SANTPERE G,DARRE F,BLANCO S,et al.Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1 000 Genomes Project[J]. Genome Biol Evol,2014,6(4): 846-860.
|
[25] |
张敏杰,张阳,徐丹,等. 中国人群EB病毒感染与系统性红斑狼疮相关性的Meta分析[J]. 现代检验医学杂志,2018,33(1):25-31.
|
[26] |
DE PASCHALE M,CLERICI P.Serological diagnosis of Epstein-Barr virus infection:problems and solutions[J]. World J Virol,2012,1(1):31-43.
|
[27] |
GUERRERO-RAMOS A,PATEL M,KADAKIA K,et al.Performance of the architect EBV antibody panel for determination of Epstein-Barr virus infection stage in immunocompetent adolescents and young adults with clinical suspicion of infectious mononucleosis[J]. Clin Vaccine Immunol,2014,21(6):817-823.
|
[28] |
DE ORY F,GUISASOLA M E,SANZ J C,et al.Evaluation of four commercial systems for the diagnosis of Epstein-Barr virus primary infections[J]. Clin Vaccine Immunol,2011,18(3):444-448.
|
[29] |
罗耀凌,欧国萍,池沛冬,等. 联合检测EB病毒相关抗体和抗原对诊断鼻咽癌的价值[J]. 癌症,2009,28(1):96-99.
|
[30] |
LIU Y,HUANG Q,LIU W,et al.Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma:a two-stage design with a preliminary performance study and a mass screening in southern China[J]. Int J Cancer,2012,131(2):406-416.
|
[31] |
BAUER G.Simplicity through complexity:immunoblot with recombinant antigens as the new gold standard in Epstein-Barr virus serology[J]. Clin Lab,2001,47(5-6): 223-230.
|
[32] |
许健,吴蓉,相芬芬,等. EB病毒再激活过程中HLA优势基因型的分析[J]. 检验医学,2017,32(6):535-539.
|